UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma

Neuro-oncology (Charlottesville, Va.), 2016-08, Vol.18 (8), p.1137-1145

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma

Journal of clinical oncology, 2011-09, Vol.29 (27), p.3611-3619

2011

Link zum Volltext

Verfügbarkeit prüfen

Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program

Journal of neuro-oncology, 2014-02, Vol.116 (3), p.609-616

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1044-1049

2003

Link zum Volltext

Verfügbarkeit prüfen

Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy

Advances in radiation oncology, 2021-07, Vol.6 (4), p.100711, Article 100711

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT110: Phase II multicenter study of gene-mediated cytotoxic immunotherapy as an adjuvant to surgical resection for newly diagnosed malignant glioma: lessons learned from pseudo-progression and a nine-year survivor

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT110-CT110

2016

Link zum Volltext

Verfügbarkeit prüfen

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma

Frontiers in neurology, 2016-08, Vol.7, p.121-121

2016

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response

Frontiers in neurology, 2017-07, Vol.8, p.311-311

2017

Link zum Volltext

Verfügbarkeit prüfen

NIMG-59. MAGNETIC RESONANCE IMAGING SEQUENCE ARTERIAL SPIN LABELING (ASL) IN THE MONITORING OF PATIENTS WITH GLIOMA: AN AID IN DETERMINING PROGRESSION VS. TREATMENT CHANGE

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi137-vi137

2016

Link zum Volltext

Verfügbarkeit prüfen

NT-26 PATHOLOGY OF CASES OF IMAGING PROGRESSION IN PATIENTS DIAGNOSED WITH GLIOBLASTOMA WHO HAVE BEEN TREATED WITH THE NOVOCURE - TTF DEVICE IN THE EF-14 TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v164-v164

2014

Link zum Volltext

Verfügbarkeit prüfen

NT-26PATHOLOGY OF CASES OF IMAGING PROGRESSION IN PATIENTS DIAGNOSED WITH GLIOBLASTOMA WHO HAVE BEEN TREATED WITH THE NOVOCURE - TTF DEVICE IN THE EF-14 TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v164-v164

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-03, Vol.17 (3), p.430-439

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiation injury to the nervous system

Current opinion in neurology, 2001-12, Vol.14 (6), p.725-734

New, P

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4402: Lazaroid formulations for brain delivery in treatment of glioblastoma multiforme

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4402-4402

2015

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase in the treatment of glioma: its complex role in signal transduction

Cancer control, 2004-05, Vol.11 (3), p.152-164

New, Pamela

2004

Link zum Volltext

Verfügbarkeit prüfen

Poor drug distribution as a possible explanation for the results of the PRECISE trial

Journal of neurosurgery, 2010-08, Vol.113 (2), p.301-309

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-02, Vol.17 (2), p.266-273

2015

Link zum Volltext

Verfügbarkeit prüfen

Early recurrence in glioblastoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e13032-e13032

2013

Link zum Volltext

Verfügbarkeit prüfen

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.O11-O11, Article O11

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of lazaroid U-74389G liposomes in a glioblastoma mouse model

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2098-2098

2012

Link zum Volltext

Verfügbarkeit prüfen

Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa. Case report and review of the literature

Journal of neurosurgery, 2001-09, Vol.95 (3), p.507

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2652: Formulation and pharmacokinetics of Lazaroid U-74389G (LAZ) liposomes in rats

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2652-2652

2010

Link zum Volltext

Verfügbarkeit prüfen

IMCT-02PHASE II MULTICENTER STUDY OF GENE MEDIATED CYTOTOXIC IMMUNOTHERAPY AS ADJUVANT TO SURGICAL RESECTION FOR NEWLY DIAGNOSED MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v107.2-v107

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II multicenter study of gene mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2010-2010

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(138)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(176)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(82)
Humans
(57)
Female
(38)
Biological And Medical Sciences
(30)
Adult
(29)
Male
(28)
Middle Aged
(25)
Oncology
(23)
Aged
(19)
Medical Sciences
(19)
Neurosciences & Neurology
(16)
Clinical Neurology
(15)
Treatment Outcome
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Adolescent
(10)
Animals
(10)
Radiology, Nuclear Medicine & Medical Imaging
(10)
Retrospective Studies
(10)
Chief Executive Officers
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma

Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma

Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program

Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy

Abstract CT110: Phase II multicenter study of gene-mediated cytotoxic immunotherapy as an adjuvant to surgical resection for newly diagnosed malignant glioma: lessons learned from pseudo-progression and a nine-year survivor

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response

NIMG-59. MAGNETIC RESONANCE IMAGING SEQUENCE ARTERIAL SPIN LABELING (ASL) IN THE MONITORING OF PATIENTS WITH GLIOMA: AN AID IN DETERMINING PROGRESSION VS. TREATMENT CHANGE

NT-26 PATHOLOGY OF CASES OF IMAGING PROGRESSION IN PATIENTS DIAGNOSED WITH GLIOBLASTOMA WHO HAVE BEEN TREATED WITH THE NOVOCURE - TTF DEVICE IN THE EF-14 TRIAL

NT-26PATHOLOGY OF CASES OF IMAGING PROGRESSION IN PATIENTS DIAGNOSED WITH GLIOBLASTOMA WHO HAVE BEEN TREATED WITH THE NOVOCURE - TTF DEVICE IN THE EF-14 TRIAL

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Radiation injury to the nervous system

Abstract 4402: Lazaroid formulations for brain delivery in treatment of glioblastoma multiforme

Cyclooxygenase in the treatment of glioma: its complex role in signal transduction

Poor drug distribution as a possible explanation for the results of the PRECISE trial

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Early recurrence in glioblastoma

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Effects of lazaroid U-74389G liposomes in a glioblastoma mouse model

Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa. Case report and review of the literature

Abstract 2652: Formulation and pharmacokinetics of Lazaroid U-74389G (LAZ) liposomes in rats

IMCT-02PHASE II MULTICENTER STUDY OF GENE MEDIATED CYTOTOXIC IMMUNOTHERAPY AS ADJUVANT TO SURGICAL RESECTION FOR NEWLY DIAGNOSED MALIGNANT GLIOMA

Phase II multicenter study of gene mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma

Suchergebnisse filtern